D
Diagnos Inc.
DGNOF
$0.2113
$0.00371.78%
D
Sell
8/6/2024Upgraded
Diagnos Inc. (DGNOF) was upgraded to D- from E+ on 8/6/2024 due to an increase in the volatility index.
Diagnos Inc. (DGNOF) was upgraded to D- from E+ on 8/6/2024 due to an increase in the volatility index.
E
Sell
7/22/2024Downgrade
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 7/22/2024 due to a decline in the growth index, volatility index and solvency index. The quick ratio declined from 0.59 to 0.21, total revenue declined 18.54% from $38.3 to $31.2, and debt to equity increased from -1.01 to -1.
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 7/22/2024 due to a decline in the growth index, volatility index and solvency index. The quick ratio declined from 0.59 to 0.21, total revenue declined 18.54% from $38.3 to $31.2, and debt to equity increased from -1.01 to -1.
D
Sell
7/15/2024Upgraded
Diagnos Inc. (DGNOF) was upgraded to D- from E+ on 7/15/2024 due to an increase in the volatility index, total return index and valuation index.
Diagnos Inc. (DGNOF) was upgraded to D- from E+ on 7/15/2024 due to an increase in the volatility index, total return index and valuation index.
E
Sell
6/28/2024Downgrade
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 6/28/2024 due to a decline in the volatility index and valuation index.
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 6/28/2024 due to a decline in the volatility index and valuation index.
D
Sell
6/13/2024Upgraded
Diagnos Inc. (DGNOF) was upgraded to D- from E+ on 6/13/2024 due to an increase in the volatility index, total return index and valuation index.
Diagnos Inc. (DGNOF) was upgraded to D- from E+ on 6/13/2024 due to an increase in the volatility index, total return index and valuation index.
E
Sell
5/29/2024Downgrade
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 5/29/2024 due to a decline in the volatility index.
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 5/29/2024 due to a decline in the volatility index.
D
Sell
5/14/2024Upgraded
Diagnos Inc. (DGNOF) was upgraded to D- from E+ on 5/14/2024 due to an increase in the total return index and volatility index.
Diagnos Inc. (DGNOF) was upgraded to D- from E+ on 5/14/2024 due to an increase in the total return index and volatility index.
E
Sell
4/26/2024Downgrade
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 4/26/2024 due to a decline in the volatility index.
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 4/26/2024 due to a decline in the volatility index.
D
Sell
4/11/2024Upgraded
Diagnos Inc. (DGNOF) was upgraded to D- from E+ on 4/11/2024 due to an increase in the volatility index.
Diagnos Inc. (DGNOF) was upgraded to D- from E+ on 4/11/2024 due to an increase in the volatility index.
E
Sell
3/21/2024Downgrade
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 3/21/2024 due to a decline in the volatility index and total return index.
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 3/21/2024 due to a decline in the volatility index and total return index.
D
Sell
3/6/2024Upgraded
Diagnos Inc. (DGNOF) was upgraded to D- from E+ on 3/6/2024 due to an increase in the volatility index and valuation index.
Diagnos Inc. (DGNOF) was upgraded to D- from E+ on 3/6/2024 due to an increase in the volatility index and valuation index.
E
Sell
2/26/2024Downgrade
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 2/26/2024 due to a noticeable decline in the growth index, volatility index and solvency index. The quick ratio declined from 1.21 to 0.65, total revenue declined 24.22% from $32.2 to $24.4, and debt to equity increased from -1.26 to -1.08.
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 2/26/2024 due to a noticeable decline in the growth index, volatility index and solvency index. The quick ratio declined from 1.21 to 0.65, total revenue declined 24.22% from $32.2 to $24.4, and debt to equity increased from -1.26 to -1.08.
D
Sell
3/14/2023Downgrade
Diagnos Inc. (DGNOF) was downgraded to D- from D+ on 03/14/2023.
Diagnos Inc. (DGNOF) was downgraded to D- from D+ on 03/14/2023.
D
Sell
2/9/2023Upgraded
Diagnos Inc. (DGNOF) was upgraded to D+ from D- on 02/09/2023.
Diagnos Inc. (DGNOF) was upgraded to D+ from D- on 02/09/2023.
D
Sell
2/8/2023Downgrade
Diagnos Inc. (DGNOF) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index.
Diagnos Inc. (DGNOF) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index.
D
Sell
1/27/2023Downgrade
Diagnos Inc. (DGNOF) was downgraded to D from D+ on 1/27/2023 due to a decline in the solvency index and valuation index.
Diagnos Inc. (DGNOF) was downgraded to D from D+ on 1/27/2023 due to a decline in the solvency index and valuation index.
D
Sell
11/28/2022Upgraded
Diagnos Inc. (DGNOF) was upgraded to D+ from D on 11/28/2022 due to an increase in the valuation index and volatility index.
Diagnos Inc. (DGNOF) was upgraded to D+ from D on 11/28/2022 due to an increase in the valuation index and volatility index.
D
Sell
5/16/2022Upgraded
Diagnos Inc. (DGNOF) was upgraded to D from E+ on 5/16/2022 due to an increase in the valuation index.
Diagnos Inc. (DGNOF) was upgraded to D from E+ on 5/16/2022 due to an increase in the valuation index.
E
Sell
5/13/2022Downgrade
Diagnos Inc. (DGNOF) was downgraded to E+ from D on 05/13/2022.
Diagnos Inc. (DGNOF) was downgraded to E+ from D on 05/13/2022.
D
Sell
5/4/2022Upgraded
Diagnos Inc. (DGNOF) was upgraded to D from E+ on 05/04/2022.
Diagnos Inc. (DGNOF) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/1/2022Downgrade
Diagnos Inc. (DGNOF) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
Diagnos Inc. (DGNOF) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
D
Sell
4/21/2022Upgraded
Diagnos Inc. (DGNOF) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index.
Diagnos Inc. (DGNOF) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index.
E
Sell
4/20/2022Downgrade
Diagnos Inc. (DGNOF) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.33 to 1.63, and the quick ratio declined from 1.8 to 1.31.
Diagnos Inc. (DGNOF) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.33 to 1.63, and the quick ratio declined from 1.8 to 1.31.
D
Sell
11/23/2021Upgraded
Diagnos Inc. (DGNOF) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
Diagnos Inc. (DGNOF) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
Diagnos Inc. (DGNOF) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
Diagnos Inc. (DGNOF) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
D
Sell
8/28/2020Upgraded
Diagnos Inc. (DGNOF) was upgraded to D from D- on 8/28/2020 due to a large increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0192 to -$0.0058, operating cash flow increased 65.7% from -$873.3 to -$299.5, and EBIT increased 43.95% from -$807.9 to -$452.8.
Diagnos Inc. (DGNOF) was upgraded to D from D- on 8/28/2020 due to a large increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0192 to -$0.0058, operating cash flow increased 65.7% from -$873.3 to -$299.5, and EBIT increased 43.95% from -$807.9 to -$452.8.
D
Sell
6/5/2020Downgrade
Diagnos Inc. (DGNOF) was downgraded to D- from D on 6/5/2020 due to a noticeable decline in the growth index, valuation index and total return index. Operating cash flow declined 121.09% from -$395 to -$873.3, EBIT declined 103.5% from -$397 to -$807.9, and earnings per share declined from -$0.0101 to -$0.0192.
Diagnos Inc. (DGNOF) was downgraded to D- from D on 6/5/2020 due to a noticeable decline in the growth index, valuation index and total return index. Operating cash flow declined 121.09% from -$395 to -$873.3, EBIT declined 103.5% from -$397 to -$807.9, and earnings per share declined from -$0.0101 to -$0.0192.
D
Sell
5/1/2020Upgraded
Diagnos Inc. (DGNOF) was upgraded to D from E+ on 5/1/2020 due to an increase in the total return index and valuation index.
Diagnos Inc. (DGNOF) was upgraded to D from E+ on 5/1/2020 due to an increase in the total return index and valuation index.
E
Sell
3/6/2020Downgrade
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 3/6/2020 due to a decline in the growth index. Operating cash flow declined 66.32% from -$237.5 to -$395, and EBIT declined 0.4% from -$395.4 to -$397.
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 3/6/2020 due to a decline in the growth index. Operating cash flow declined 66.32% from -$237.5 to -$395, and EBIT declined 0.4% from -$395.4 to -$397.
D
Sell
3/3/2020Downgrade
Diagnos Inc. (DGNOF) was downgraded to D- from D on 3/3/2020 due to a decline in the volatility index.
Diagnos Inc. (DGNOF) was downgraded to D- from D on 3/3/2020 due to a decline in the volatility index.
D
Sell
2/13/2020Upgraded
Diagnos Inc. (DGNOF) was upgraded to D from D- on 2/13/2020 due to an increase in the growth index and volatility index. Earnings per share increased from -$0.0245 to -$0.0103, operating cash flow increased 49.75% from -$472.6 to -$237.5, and EBIT increased 20.43% from -$496.9 to -$395.4.
Diagnos Inc. (DGNOF) was upgraded to D from D- on 2/13/2020 due to an increase in the growth index and volatility index. Earnings per share increased from -$0.0245 to -$0.0103, operating cash flow increased 49.75% from -$472.6 to -$237.5, and EBIT increased 20.43% from -$496.9 to -$395.4.
D
Sell
10/29/2019Downgrade
Diagnos Inc. (DGNOF) was downgraded to D- from D on 10/29/2019 due to a decline in the total return index and volatility index.
Diagnos Inc. (DGNOF) was downgraded to D- from D on 10/29/2019 due to a decline in the total return index and volatility index.
D
Sell
7/5/2019Upgraded
Diagnos Inc. (DGNOF) was upgraded to D from D- on 7/5/2019 due to an increase in the growth index and valuation index. Operating cash flow increased 62.75% from -$697.8 to -$259.9, earnings per share increased from -$0.0402 to -$0.0265, and EBIT increased 23.21% from -$572.7 to -$439.8.
Diagnos Inc. (DGNOF) was upgraded to D from D- on 7/5/2019 due to an increase in the growth index and valuation index. Operating cash flow increased 62.75% from -$697.8 to -$259.9, earnings per share increased from -$0.0402 to -$0.0265, and EBIT increased 23.21% from -$572.7 to -$439.8.
D
Sell
2/28/2019Downgrade
Diagnos Inc. (DGNOF) was downgraded to D- from D on 2/28/2019 due to a decline in the solvency index.
Diagnos Inc. (DGNOF) was downgraded to D- from D on 2/28/2019 due to a decline in the solvency index.
D
Sell
1/8/2019Upgraded
Diagnos Inc. (DGNOF) was upgraded to D from D- on 1/8/2019 due to an increase in the total return index and volatility index.
Diagnos Inc. (DGNOF) was upgraded to D from D- on 1/8/2019 due to an increase in the total return index and volatility index.
D
Sell
12/24/2018Downgrade
Diagnos Inc. (DGNOF) was downgraded to D- from D on 12/24/2018 due to a substantial decline in the growth index, total return index and solvency index. Operating cash flow declined 520.71% from -$112 to -$695.2, the quick ratio declined from 0.51 to 0.17, and total revenue declined 49.45% from $72.2 to $36.5.
Diagnos Inc. (DGNOF) was downgraded to D- from D on 12/24/2018 due to a substantial decline in the growth index, total return index and solvency index. Operating cash flow declined 520.71% from -$112 to -$695.2, the quick ratio declined from 0.51 to 0.17, and total revenue declined 49.45% from $72.2 to $36.5.
D
Sell
10/2/2018Downgrade
Diagnos Inc. (DGNOF) was downgraded to D from D+ on 10/2/2018 due to a decline in the volatility index.
Diagnos Inc. (DGNOF) was downgraded to D from D+ on 10/2/2018 due to a decline in the volatility index.
D
Sell
9/17/2018Upgraded
Diagnos Inc. (DGNOF) was upgraded to D+ from D on 9/17/2018 due to a substantial increase in the growth index, volatility index and total return index. Operating cash flow increased 87.2% from -$874.7 to -$112, total revenue increased 37% from $52.7 to $72.2, and earnings per share increased from -$0.0048 to -$0.0043.
Diagnos Inc. (DGNOF) was upgraded to D+ from D on 9/17/2018 due to a substantial increase in the growth index, volatility index and total return index. Operating cash flow increased 87.2% from -$874.7 to -$112, total revenue increased 37% from $52.7 to $72.2, and earnings per share increased from -$0.0048 to -$0.0043.
D
Sell
8/14/2018Upgraded
Diagnos Inc. (DGNOF) was upgraded to D from D- on 8/14/2018 due to a large increase in the solvency index, growth index and valuation index.
Diagnos Inc. (DGNOF) was upgraded to D from D- on 8/14/2018 due to a large increase in the solvency index, growth index and valuation index.
D
Sell
7/6/2017Downgrade
Diagnos Inc. (DGNOF) was downgraded to D- from D on 7/6/2017 due to a decline in the valuation index, total return index and solvency index.
Diagnos Inc. (DGNOF) was downgraded to D- from D on 7/6/2017 due to a decline in the valuation index, total return index and solvency index.
D
Sell
6/21/2017Upgraded
Diagnos Inc. (DGNOF) was upgraded to D from D- on 6/21/2017 due to a substantial increase in the total return index and volatility index.
Diagnos Inc. (DGNOF) was upgraded to D from D- on 6/21/2017 due to a substantial increase in the total return index and volatility index.
D
Sell
11/17/2016Downgrade
Diagnos Inc. (DGNOF) was downgraded to D- from D on 11/17/2016 due to a noticeable decline in the growth index, solvency index and volatility index. EBIT declined 40.85% from -$428.4 to -$603.4, operating cash flow declined 29.2% from -$331.8 to -$428.7, and earnings per share declined from -$0.005 to -$0.006.
Diagnos Inc. (DGNOF) was downgraded to D- from D on 11/17/2016 due to a noticeable decline in the growth index, solvency index and volatility index. EBIT declined 40.85% from -$428.4 to -$603.4, operating cash flow declined 29.2% from -$331.8 to -$428.7, and earnings per share declined from -$0.005 to -$0.006.
D
Sell
8/24/2016Upgraded
Diagnos Inc. (DGNOF) was upgraded to D from D- on 8/24/2016 due to a noticeable increase in the growth index and valuation index. Total revenue increased 17.3% from $175.7 to $206.1, EBIT increased 9.04% from -$471 to -$428.4, and earnings per share increased from -$0.0054 to -$0.005.
Diagnos Inc. (DGNOF) was upgraded to D from D- on 8/24/2016 due to a noticeable increase in the growth index and valuation index. Total revenue increased 17.3% from $175.7 to $206.1, EBIT increased 9.04% from -$471 to -$428.4, and earnings per share increased from -$0.0054 to -$0.005.
D
Sell
7/18/2016Upgraded
Diagnos Inc. (DGNOF) was upgraded to D- from E+ on 7/18/2016 due to a significant increase in the solvency index, growth index and valuation index.
Diagnos Inc. (DGNOF) was upgraded to D- from E+ on 7/18/2016 due to a significant increase in the solvency index, growth index and valuation index.
E
Sell
7/1/2016Downgrade
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 7/1/2016 due to a significant decline in the solvency index, growth index and valuation index. The quick ratio declined from 0.65 to 0.4.
Diagnos Inc. (DGNOF) was downgraded to E+ from D- on 7/1/2016 due to a significant decline in the solvency index, growth index and valuation index. The quick ratio declined from 0.65 to 0.4.
D
Sell
3/11/2016Downgrade
Diagnos Inc. (DGNOF) was downgraded to D- from D on 3/11/2016 due to a substantial decline in the volatility index, total return index and solvency index. The quick ratio declined from 1.09 to 0.65, and debt to equity increased from -2.22 to -1.51.
Diagnos Inc. (DGNOF) was downgraded to D- from D on 3/11/2016 due to a substantial decline in the volatility index, total return index and solvency index. The quick ratio declined from 1.09 to 0.65, and debt to equity increased from -2.22 to -1.51.
D
Sell
7/15/2015Upgraded
Diagnos Inc. (DGNOF) was upgraded to D from D- on 7/15/2015 due to an increase in the volatility index and total return index.
Diagnos Inc. (DGNOF) was upgraded to D from D- on 7/15/2015 due to an increase in the volatility index and total return index.
D
Sell
3/23/2015Downgrade
Diagnos Inc. (DGNOF) was downgraded to D- from D on 3/23/2015 due to a significant decline in the growth index, valuation index and solvency index. Debt to equity increased from 0.85 to 2.16, operating cash flow declined 43.76% from -$946.3 to -$532.2, and EBIT declined 20.07% from -$675 to -$539.5.
Diagnos Inc. (DGNOF) was downgraded to D- from D on 3/23/2015 due to a significant decline in the growth index, valuation index and solvency index. Debt to equity increased from 0.85 to 2.16, operating cash flow declined 43.76% from -$946.3 to -$532.2, and EBIT declined 20.07% from -$675 to -$539.5.
D
Sell
8/27/2014Upgraded
Diagnos Inc. (DGNOF) was upgraded to D from D- on 8/27/2014 due to an increase in the valuation index, growth index and solvency index. Debt to equity declined from 1.8 to -2.93, operating cash flow increased 81.12% from -$457.1 to -$827.9, and earnings per share increased from -$0.0063 to -$0.0081.
Diagnos Inc. (DGNOF) was upgraded to D from D- on 8/27/2014 due to an increase in the valuation index, growth index and solvency index. Debt to equity declined from 1.8 to -2.93, operating cash flow increased 81.12% from -$457.1 to -$827.9, and earnings per share increased from -$0.0063 to -$0.0081.
D
Sell
7/7/2014Downgrade
Diagnos Inc. (DGNOF) was downgraded to D- from D on 7/7/2014 due to a major decline in the growth index, solvency index and efficiency index. Operating cash flow declined 501.32% from $113.9 to -$457.1, and total revenue declined 69.63% from $438.9 to $133.3.
Diagnos Inc. (DGNOF) was downgraded to D- from D on 7/7/2014 due to a major decline in the growth index, solvency index and efficiency index. Operating cash flow declined 501.32% from $113.9 to -$457.1, and total revenue declined 69.63% from $438.9 to $133.3.
OTC PK
03/14/2025 11:59AM Eastern
Quotes delayed
